The breast cancer liquid biopsy testing devices market is poised to grow by USD 479.83 million during 2020-2024 progressing at a CAGR of almost 24% during the forecast period.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis
The report on the breast cancer liquid biopsy testing devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005690/en/
Technavio has announced its latest market research report titled Global Breast Cancer Liquid Biopsy Testing Devices Market 2020-2024 (Graphic: Business Wire)
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the enhanced emphasis on personalized medicine.
The breast cancer liquid biopsy testing devices market analysis includes the type and geography landscape. This study identifies the increasing focus on direct-to-customer marketing as one of the prime reasons driving breast cancer liquid biopsy testing devices market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters
The Breast Cancer Liquid Biopsy Testing Devices market covers the following areas:
Breast Cancer Liquid Biopsy Testing Devices Market Sizing
Breast Cancer Liquid Biopsy Testing Devices Market Forecast
Breast Cancer Liquid Biopsy Testing Devices Market Analysis
Companies Mentioned
- Menarini Industrie Farmaceutiche Riunite Srl
- Biocept Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Genomic Health Inc.
- Illumina Inc.
- Myriad Genetics Inc.
- Natera Inc.
- QIAGEN NV
- and Thermo Fisher Scientific Inc.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- CTCs and circulating nucleic acids Market size and forecast 2019-2024
- Extracellular vesicles Market size and forecast 2019-2024
- Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America Market size and forecast 2019-2024
- Europe Market size and forecast 2019-2024
- Asia Market size and forecast 2019-2024
- ROW Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Technological advances
- Enhanced emphasis on personalized medicine
- Increasing focus on direct-to-customer marketing
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Menarini Industrie Farmaceutiche Riunite Srl
- Biocept Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Genomic Health Inc.
- Illumina Inc.
- Myriad Genetics Inc.
- Natera Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201102005690/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/